Review highlights systemic candidiasis infection risks and pathogen variation in immunocompromised patients, indicating rising medical mycology concerns.
Systemic candidiasis currently occupies one of the first places in medical mycology and infectious diseases. Whereas Candida albicans had previously been the dominant pathogen, this species now accounts for only half of the isolates detected in many surveys. The distinction between them is made taking into account their biological properties, manifested in the mycological analysis. Infections by Candida sp. have increased dramatically in recent decades. The development of new invasive techniques increases the risk in immunocompromised patients. The objective of this review is to present general aspects of systemic candidiasis.
No takes yet. Share an insight, caveat, or question.
Céspedes et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: